HVIVO PLC — Investor Relations & Filings
hVIVO plc is a full-service contract research organization (CRO) and a leading specialist in human challenge trials. The company provides end-to-end clinical development solutions for a global biopharma client base, focusing on infectious and respiratory diseases. Its services span from preclinical consultancy to Phase III clinical trials, including first-in-human studies, biometry, and consulting. hVIVO operates a state-of-the-art quarantine facility in London and provides advanced laboratory services under its hLAB brand. Through subsidiaries such as CRS and Venn Life Sciences, it offers early-phase clinical trial expertise and patient recruitment across multiple clinical sites. The company's integrated approach is designed to accelerate the development of vaccines and therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Capital Markets Day | 2026-05-20 | English | |
| Result of AGM | 2026-05-13 | English | |
| Holding(s) in Company | 2026-05-12 | English | |
| £6m Influenza HCT contract signed | 2026-05-07 | English | |
| Director/PDMR Shareholding | 2026-04-24 | English | |
| HCT contract signed with ILiAD Biotechnologies | 2026-04-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46579419 | Capital Markets Day | 2026-05-20 | English | ||
| 45604509 | Result of AGM | 2026-05-13 | English | ||
| 45196271 | Holding(s) in Company | 2026-05-12 | English | ||
| 42452157 | £6m Influenza HCT contract signed | 2026-05-07 | English | ||
| 36206442 | Director/PDMR Shareholding | 2026-04-24 | English | ||
| 35137173 | HCT contract signed with ILiAD Biotechnologies | 2026-04-22 | English | ||
| 34661204 | Annual Report & Notice of AGM | 2026-04-17 | English | ||
| 34655198 | hVIVO launches unified brand identity | 2026-04-14 | English | ||
| 34655136 | Influenza HCT contract signed with Traws Pharma | 2026-04-14 | English | ||
| 33684812 | Notice of Results | 2026-04-07 | English | ||
| 33051244 | Holding(s) in Company | 2026-03-26 | English | ||
| 32851117 | Holding(s) in Company | 2026-02-27 | English | ||
| 32825702 | Issue of Equity and Total Voting Rights | 2026-02-23 | English | ||
| 28089685 | Holding(s) in Company | 2026-02-16 | English | ||
| 34558892 | Holding(s) in Company | 2026-02-11 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for HVIVO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Annovis Bio, Inc.
A clinical-stage drug platform company developing therapies…
|
ANVS | US | Professional, scientific and te… |
|
AnorMED Inc.
Developed small molecule therapeutics for serious diseases,…
|
— | CA | Professional, scientific and te… |
|
ANTEOTECH LTD
Develops nanoglue technology for life sciences and lithium-…
|
ADO | AU | Professional, scientific and te… |
|
Anthem Biosciences Limited
Integrated CRAMS organization for drug discovery, developme…
|
ANTHEM | IN | Professional, scientific and te… |
|
APPLIED DNA SCIENCES INC
Develops and manufactures DNA-based technologies for geneti…
|
APDN | US | Professional, scientific and te… |
|
Aprea Therapeutics, Inc.
Clinical-stage biopharma developing cancer therapeutics via…
|
APRE | US | Professional, scientific and te… |
|
AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases…
|
397030 | KR | Professional, scientific and te… |
|
Aptahem AB
A clinical-stage biotech developing aptamer-based drugs for…
|
APTA | SE | Professional, scientific and te… |
|
APTAMER GROUP PLC
Develops custom affinity binders for research, diagnostics,…
|
APTA | GB | Professional, scientific and te… |
|
Aptevo Therapeutics Inc.
Clinical-stage biotech developing antibody-based immunother…
|
APVO | US | Professional, scientific and te… |
HVIVO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7697/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7697 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7697 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7697 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7697}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HVIVO PLC (id: 7697)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.